Identifying Health Care Quality Measures for Medicaid-Eligible Adults: Background Report
Appendix 4. Public Comment Results (continued)
Table of Contents
B. Public Comment Results: Additional Recommended Measures
| # | Measure Name | Owner | No. Requests to Add | Organizations Requesting |
|---|---|---|---|---|
|
52 |
Adoption/Use of Medication Electronic Prescribing Measure |
CMS |
2 |
Boehringer Ingelheim Pharm |
|
53 |
Adult BMI Assessment |
NCQA |
1 |
American Academy of Family Physicians |
|
54 |
Appropriate Follow Up for Patients With HIV/AIDS |
IMS Health |
1 |
CDC Division in the National Center for HIV/AIDS, Viral Hepatitis, STD, TB Prevention |
|
55 |
Change in Basic Mobility as Measured by the AM-PAC |
CREcare |
1 |
Disability and Rehabilitation Research Coalition |
|
56 |
Change in Daily Activity Function as Measured by the AM-PAC |
CREcare |
1 |
Disability and Rehabilitation Research Coalition |
|
57 |
Chlamydia Screening in Women |
NCQA |
1 |
National Chlamydia Coalition |
|
58 |
Chronic Obstructive Pulmonary Disease (COPD): Inhaled Bronchodilator Therapy |
AMA |
1 |
Boehringer Ingelheim Pharm |
|
59 |
Chronic Obstructive Pulmonary Disease (COPD): Spirometry Evaluation |
AMA |
1 |
Boehringer Ingelheim Pharm |
|
60 |
Comprehensive Diabetes Care: Eye Exam (Retinal) Performed |
NCQA |
2 |
American Academy of Ophthalmology |
|
61 |
Functional Communication Measure—Attention |
American Speech-Language-Hearing Association |
1 |
American Speech-Language-Hearing Association |
|
62 |
Functional Communication Measure—Memory |
American Speech-Language-Hearing Association |
1 |
American Speech-Language-Hearing Association |
|
63 |
Functional Communication Measure—Motor Speech |
American Speech-Language-Hearing Association |
1 |
American Speech-Language-Hearing Association |
|
64 |
Functional Communication Measure —Reading |
American Speech-Language-Hearing Association |
1 |
American Speech-Language-Hearing Association |
|
65 |
Functional Communication Measure—Spoken Language Comprehension |
American Speech-Language-Hearing Association |
1 |
American Speech-Language-Hearing Association |
|
66 |
Functional Communication Measure—Spoken Language Expression |
American Speech-Language-Hearing Association |
1 |
American Speech-Language-Hearing Association |
|
67 |
Functional Communication Measure—Swallowing |
American Speech-Language-Hearing Association |
American Speech-Language-Hearing Association |
|
|
68 |
Functional Communication Measure—Writing |
American Speech-Language-Hearing Association |
1 |
American Speech-Language-Hearing Association |
|
69 |
Glaucoma Screening in Older Adults |
NCQA |
1 |
American Academy of Ophthalmology |
|
70 |
HBIPS-3 Hours of Seclusion Use |
TJC |
1 |
National Association of Psychiatric Health Systems |
|
71 |
HBIPS-4 Patients Discharged on Multiple Antipsychotic Medications |
TJC |
1 |
National Association of Psychiatric Health Systems |
|
72 |
HBIPS-5 Patients Discharged on Multiple Antipsychotic Medications With Appropriate Justification |
TJC |
1 |
National Association of Psychiatric Health Systems |
|
73 |
HBIPS-6 Post Discharge Continuing Care Plan Created |
TJC |
2 |
Boehringer Ingelheim Pharm |
|
74 |
HBIPS-7 Post Discharge Continuing Care Plan Transmitted to Next Level of Care Provider upon Discharge |
TJC |
1 |
National Association of Psychiatric Health Systems |
|
75 |
Health Information Technology (HIT): Adoption/Use of Electronic Health Records (EHR) |
CMS |
1 |
Boehringer Ingelheim Pharm |
|
76 |
Healthy Term Newborn |
CMQCC |
1 |
Childbirth Connections |
|
77 |
Hepatitis C: Antiviral Treatment Prescribed |
AMA |
1 |
CDC Division in the National Center for HIV/AIDS, Viral Hepatitis, STD, TB Prevention |
|
78 |
Hepatitis C: Testing for Chronic Hepatitis C—Confirmation of Hepatitis C Viremia |
AMA |
2 |
American Association for the Study of Liver Diseases |
|
79 |
HIV/AIDS Screening: Members at High Risk of HIV/AIDS |
IMS Health |
2 |
CDC Division in the National Center for HIV/AIDS, Viral Hepatitis, STD, TB Prevention |
|
80 |
HIV/AIDS: Adolescent and Adult Patients With HIV/AIDS Who Are Prescribed Potent Antiretroviral Therapy |
AMA, NCQA |
1 |
CDC Division in the National Center for HIV/AIDS, Viral Hepatitis, STD, TB Prevention |
|
81 |
HIV/AIDS: Hepatitis B Screening |
NCQA |
1 |
American Association for the Study of Liver Diseases |
|
82 |
HIV/AIDS: Tuberculosis (TB) Screening |
NCQA |
1 |
CDC Division in the National Center for HIV/AIDS, Viral Hepatitis, STD, TB Prevention |
|
83 |
Medication Reconciliation Post-Discharge |
NCQA |
1 |
Boehringer Ingelheim Pharm |
|
84 |
Pharmacotherapy of COPD Exacerbation |
NCQA |
2 |
Boehringer Ingelheim Pharm |
|
85 |
Reconciled Medication List Received by Discharged Patients (Inpatient Discharges to Home/Self Care or Any Other Site of Care) |
AMA |
2 |
Boehringer Ingelheim Pharm |
|
86 |
Risk-Adjusted Operative Mortality for CABG |
The Society of Thoracic Surgeons |
1 |
National Kidney Foundation |
|
87 |
Risk-Adjusted Operative Mortality for Mitral Valve (MV) Replacement |
The Society of Thoracic Surgeons |
1 |
National Kidney Foundation |
|
88 |
Risk-Adjusted Operative Mortality for MVR + CABG Surgery |
The Society of Thoracic Surgeons |
1 |
National Kidney Foundation |
|
89 |
Screening Foreign-born Adults for Chronic Hepatitis B |
Asian Liver Center at Stanford University |
American Association for the Study of Liver Diseases |
|
|
90 |
Severity-Standardized ALOS—Deliveries |
Leapfrog Group |
1 |
MEDCO/Health Solutions, Inc. |
|
91 |
STK-3 Anticoagulation Therapy for Atrial Fibrillation/Flutter |
TJC |
1 |
Boehringer Ingelheim Pharm |
|
92 |
Stroke and Stroke Rehabilitation: Anticoagulant Therapy Prescribed for Atrial Fibrillation at Discharge |
AMA, NCQA |
1 |
Boehringer Ingelheim Pharm |
|
93 |
Tracking of Clinical Results Between Visits |
CMS |
1 |
Childbirth Connection |
|
94 |
Use of Spirometry Testing in the Assessment and Diagnosis of COPD |
NCQA |
2 |
Boehringer Ingelheim Pharm |
Page originally created December 2010


5600 Fishers Lane Rockville, MD 20857